New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Pfizer Inc.
PFE
Shape
US Flag

NYSE

160B

Drug Manufacturers - General

Next Earning date - 29 Oct 2024

160B

Drug Manufacturers - General

Next Earning date - 29 Oct 2024

28.25USD
Shape-0.60 ( -2.10%)
Market Open
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

70%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

10%

Quote Panel

Shape
Updated October 29, 2024
1W -2.17 % 1M -2.44 % 3M -10.05 % 1Y -2.13 %

Key Metrics

Shape
  • Market Cap

    160.11B


  • Shares Outstanding

    5.67B


  • Share in Float

    5.66B


  • Dividende

    1.68


  • Earning Date

    29 Oct 2024


  • Price Target

    28.255


  • Average Volume

    30.36M


  • Beta

    0.617


  • Range

    25.2-31.54


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.pfizer.com


  • Sector

    Healthcare


Fundamentals

Shape

20.91x

P/E Ratio

2.94x

P/S Ratio

1.86x

P/B Ratio

0.8

Debt/Equity

-4.7%

Net Margin

$-0.5

EPS

How PFE compares to sector?

P/E Ratio

Relative Strength

Shape

PFE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$63B

Shape373%

2025-Revenue

$2.05

Shape48755%

2025-EPS

$21B

Shape486%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Bernstein

initialise

Previous: Not converted

2024-10-17

Now: Market Perform

Guggenheim

initialise

Previous: Not converted

2024-07-30

Now: Buy

RBC Capital

downgrade

Previous: Not converted

2024-05-28

Now: Cautious

Cowen & Co.

downgrade

Previous: Outperform

2024-01-29

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+65%

1.78
vs 1.08

Q4.22

arrow
arrow

+6%

1.14
vs 1.08

Q2.23

arrow
arrow

-26%

1.23
vs 1.67

Q3.23

arrow
arrow

-67%

0.67
vs 2.04

Q4.23

arrow
arrow

N/A

-0.17
vs 1.14

Q4.23

arrow
arrow

-91%

0.1
vs 1.14

Q1.24

arrow
arrow

N/A

0.82
vs NA

Q2.24

arrow
arrow

-51%

0.6
vs 1.23

Q3.24

arrow
arrow

-8%

0.61
vs 0.67

Q4.24

arrow
arrow

+569%

0.67
vs 0.1

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-5%

22.6B  vs 23.8B

Q4.22

arrow
arrow

+2%

24.3B  vs 23.8B

Q2.23

arrow
arrow

-29%

18.3B  vs 25.7B

Q3.23

arrow
arrow

-54%

12.7B  vs 27.7B

Q4.23

arrow
arrow

-46%

13.2B  vs 24.3B

Q4.23

arrow
arrow

-41%

14.2B  vs 24.3B

Q1.24

arrow
arrow

NA

14.9B  vs NA

Q2.24

arrow
arrow

-27%

13.3B  vs 18.3B

Q3.24

arrow
arrow

+17%

14.9B  vs 12.7B

Q4.24

arrow
arrow

+27%

18.1B  vs 14.2B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+9%

0.09
vs 0.11

Q4.22

arrow
arrow

+5%

0.05
vs 0.09

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+2%

0.02
vs 0.05

Q4.23

arrow
arrow

-2%

-0.02
vs 0.02

Q4.23

arrow
arrow

-4%

-0.04
vs -0.02

Q1.24

arrow
arrow

+3%

0.03
vs -0.04

Q2.24

arrow
arrow

+0%

0
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

3153

3.2K
vs 3.2K

-2%

Q4.22

arrow
arrow

3331

3.3K
vs 3.2K

6%

Q1.23

arrow
arrow

3175

3.2K
vs 3.3K

-5%

Q2.23

arrow
arrow

3105

3.1K
vs 3.2K

-2%

Q3.23

arrow
arrow

3002

3K
vs 3.1K

-3%

Q4.23

arrow
arrow

3020

3K
vs 3K

1%

Q1.24

arrow
arrow

2949

2.9K
vs 3K

-2%

Q2.24

arrow
arrow

2910

2.9K
vs 2.9K

-1%

Earnings Growth

Latest News